In this study, the infusion of physostigmine in 14 patients with
affective disorder who were pretreated with methscopolamine caused
significant and often profound increases in the patients' epinephrine
levels, pulse rates, and blood pressure. Since physostigmine is being used
experimentally in the treatment of elderly subjects who have Alzheimer's
disease, these cardiovascular effects may have clinical importance.